348 results on '"Lindeman, Jan H."'
Search Results
2. Increased vascular smooth muscle cell senescence in aneurysmal Fibulin-4 mutant mice
3. Bicuspid aortic valve aortopathy is characterized by embryonic epithelial to mesenchymal transition and endothelial instability
4. Kidney Tissue Proteome Profiles in Short Versus Long Duration of Delayed Graft Function - A Pilot Study in Donation After Circulatory Death Donors
5. Thoracic aortic atherosclerosis in patients with a bicuspid aortic valve; a case–control study
6. Coding and regulatory variants are associated with serum protein levels and disease
7. A histopathological classification scheme for abdominal aortic aneurysm disease
8. Results of an explorative clinical evaluation suggest immediate and persistent post-reperfusion metabolic paralysis drives kidney ischemia reperfusion injury
9. A nationwide evaluation of deceased donor kidney transplantation indicates detrimental consequences of early graft loss
10. Proteomic prediction of incident heart failure and its main subtypes
11. TElmisartan in the management of abDominal aortic aneurYsm (TEDY): The study protocol for a randomized controlled trial
12. Response to the Comment on “Long-term Prognosis After Elective Abdominal Aortic Aneurysm Repair is Poor in Women and Men”
13. Proteomic prediction of incident heart failure and its main subtypes.
14. Response to Comment Made on “Long-term Prognosis After Elective Abdominal Aortic Aneurysm Repair is Poor in Women and Men”
15. Abstract 533: Doxycycline Fuels Mitochondrial Dysfunction In Aortic Smooth Muscle Cells
16. Long-term Prognosis After Elective Abdominal Aortic Aneurysm Repair is Poor in Women and Men: The Challenges Remain
17. Persistent High Long-term Excess Mortality After Elective AAA Repair Especially in Women.
18. PCSK6 Is a Key Protease in the Control of Smooth Muscle Cell Function in Vascular Remodeling
19. The Neglectable Impact of Delayed Graft Function on Long-term Graft Survival in Kidneys Donated After Circulatory Death Associates With Superior Organ Resilience
20. Histological evaluation disqualifies IMT and calcification scores as surrogates for grading coronary and aortic atherosclerosis
21. Excess Mortality for Abdominal Aortic Aneurysms and the Potential of Strict Implementation of Cardiovascular Risk Management: A Multifaceted Study Integrating Meta-Analysis, National Registry, and PHAST and TEDY Trial Data
22. Histological evaluation of the aortic wall response following endovascular aneurysm repair and endovascular aneurysm sealing
23. Risk for acquired coronary artery disease in genetic vs. congenital thoracic aortopathy
24. Effects of doxycycline on local and systemic inflammation in stable COPD patients, a randomized clinical trial
25. Additional file 1 of Thoracic aortic atherosclerosis in patients with a bicuspid aortic valve; a case–control study
26. Pharmacologic Management of Aneurysms
27. No Clinical Benefit of Intramuscular Delivery of Bone Marrow-derived Mononuclear Cells in Nonreconstructable Peripheral Arterial Disease: Results of a Phase-III Randomized-controlled Trial
28. Are Thoracic Aortic Aneurysm Patients at Increased Risk for Cardiovascular Diseases?
29. Prevention of vasoplegia with CytoSorb in heart failure patients undergoing cardiac surgery (CytoSorb-HF trial): protocol for a randomised controlled trial
30. Normal and abnormal development of the aortic valve and ascending aortic wall: an overview of the embryology and pathology of the bicuspid aortic valve.
31. Normal and abnormal development of the aortic valve and ascending aortic wall: a comprehensive overview of the embryology and pathology of the bicuspid aortic valve
32. Metabolically induced liver inflammation leads to NASH and differs from LPS- or IL-1β-induced chronic inflammation
33. The role of flavin mononucleotide (FMN) as a potentially clinically relevant biomarker to predict the quality of kidney grafts during hypothermic (oxygenated) machine perfusion.
34. Are Thoracic Aortic Aneurysm Patients at Increased Risk for Cardiovascular Diseases?
35. Re: “One Step Forward, Two Steps Backward”
36. Modest but impactful: Commentary on immunosuppressive drugs for nontransplant comorbidities are not associated with abdominal aortic aneurysm growth
37. Distinct Defects in Collagen Microarchitecture Underlie Vessel-Wall Failure in Advanced Abdominal Aneurysms and Aneurysms in Marfan Syndrome
38. Comparative evaluation of coronary disease burden: Bicuspid valve disease is not atheroprotective: Bicuspid valve disease is not atheroprotective
39. The quest for the mechanism(s) driving clinical ischemia-reperfusion injury - reductive rather than oxidative stress?
40. Parallel Murine and Human Aortic Wall Genomics Reveals Metabolic Reprogramming as Key Driver of Abdominal Aortic Aneurysm Progression
41. Comparative evaluation of coronary disease burden: bicuspid valve disease is not atheroprotective
42. Interleukin-9 release from human kidney grafts and its potential protective role in renal ischemia/reperfusion injury
43. Deceased donor kidney degradomics indicates cytoskeletal proteolytic alterations impacting post-transplant function
44. Extent of Coronary Artery Disease in Patients With Stenotic Bicuspid Versus Tricuspid Aortic Valves
45. Proteoglycan 4 Modulates Osteogenic Smooth Muscle Cell Differentiation during Vascular Remodeling and Intimal Calcification
46. Quantitative profiling of oxylipins through comprehensive LC-MS/MS analysis: application in cardiac surgery
47. Chronic TNF-α Neutralization Does Not Improve Insulin Resistance or Endothelial Function in “Healthy” Men with Metabolic Syndrome
48. VEGF-B-induced vascular growth leads to metabolic reprogramming and ischemia resistance in the heart
49. A Systematic Histopathologic Evaluation of Type-A Aortic Dissections Implies a Uniform Multiple-Hit Causation
50. Donor pre-treatment in clinical kidney transplantation: a critical appraisal
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.